| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2025―Nov―26 |
Impact of COVID-19 Infection on Blood Pressure Variability and Cardiovascular Outcomes in Hypertensive Patients After Complete Liberalization of Epidemic Control in China |
Quanbin Su, Mingming Wang, Jing Yu |
| 2 |
[GO] |
2025―Jul―21 |
Lessons Learned From COVID-19: Never Lower the Guard in Promoting Hypertension Awareness |
Giacomo Pucci, Chiara Giacinti, Guido Grassi |
| 3 |
[GO] |
2025―Jul―21 |
Hypertension Prevalence, Awareness, and Control in US Adults Before and After the COVID-19 Pandemic |
Mohammed Essa, Devesh Malik, Yuan Lu, Huanhuan Yang, Erica S. Spatz, Harlan M. Krumholz, Kamil F. Faridi |
| 4 |
[GO] |
2025―Feb―26 |
Antihypertensive Drug Use and COVID-19 Disease Severity in Hospitalized US Veterans: A Retrospective Cohort Study |
Merodean Huntsman, Jessica L. Marquez, Gregory J. Stoddard, Guo Wei, Aaron J. Miller, Jayant P. Agarwal, Sujee Jeyapalina |
| 5 |
[GO] |
2025―Feb―17 |
Cardiac Baroreflex Is Preserved After the Recovery From COVID-19 Men and Women |
Roberto Souza, Beatriz Divino, Helena N. M. Rocha, Jocemir R. Lugon, Natalia G. Rocha, Antonio C. L. Nobrega, Eliza Prodel |
| 6 |
[GO] |
2024―Jul―14 |
Association between renin-angiotensin antagonism and COVID-19-related mortality in patients with essential hypertension: A single center, retrospective cohort study |
Vijayvardhan Kamalumpundi, Shuntaro Kawasaki, Linhai Cheng, Erin E. Meyers, Elham Shams, Ologibe Ofori, Assim Eddin, Marcelo L. G. Correia |
| 7 |
[GO] |
2024―Jan―15 |
Trends in blood pressure changes and hypertension prevalence in Australian adults before and during the COVID-19 pandemic |
Janis M. Nolde, Fleur Streets, Denny Meyer, Won Sun Chen, Jiajun Wei, Nilmini Wickramasinghe, Patrick Hannebery, Gavin W. Lambert, Markus P. Schlaich |
| 8 |
[GO] |
2023―Mar―15 |
Hypertension care during the COVID-19 pandemic in an integrated health care system |
John F. Steiner, J. David Powers, Allen Malone, Jason Lyons, Kari Olson, Andrea R. Paolino, Claudia A. Steiner |
| 9 |
[GO] |
2022―Mar―21 |
Impact of more variations on in-hospital mortality among patients with confirmed Covid-19 |
Na Jia, Ping Zeng, Jun Xia, Deping Liu |
| 10 |
[GO] |
2022―Mar―21 |
Temporal variation, socioeconomic status, and out-of-hospital deaths as factors that influence mortality rates among hospitalized COVID-19 patients receiving ACEIs/ARBs |
Owais M. Aftab, Anurag Modak, Jai C. Patel |
| 11 |
[GO] |
2022―Feb―07 |
Prognostic significance of day-by-day in-hospital blood pressure variability in COVID-19 patients with hypertension |
Chunyan He, Chuan Liu, Jie Yang, Hu Tan, Xiaohan Ding, Xubin Gao, Yuanqi Yang, Yang Shen, Hedong Xiang, Jingbin Ke, Fangzhengyuan Yuan, Renzheng Chen, Ran Cheng, Hailin Lv, Ping Li, Limin Zhang, Lan Huang |
| 12 |
[GO] |
2022―Feb―07 |
Day-to-day blood pressure variability in COVID-19: A biomarker of disrupted central autonomic network |
Michiaki Nagai, Carola Yvette Förster |
| 13 |
[GO] |
2022―Jan―27 |
Mortality associated with COVID-19 and hypertension in sub-Saharan Africa. A systematic review and meta-analysis |
Ben Bepouka, Hippolyte Situakibanza, Modibo Sangare, Madone Mandina, Nadine Mayasi, Murielle Longokolo, Ossam Odio, Donatien Mangala, Fiston Isekusu, Jean Marie Kayembe, Jean Nachega, Marcel Mbula |
| 14 |
[GO] |
2021―Jul―31 |
Day-by-day blood pressure variability in hospitalized patients with COVID-19 |
Fei-Ka Li, De-Wei An, Qian-Hui Guo, Yi-Qing Zhang, Jia-Ye Qian, Wei-Guo Hu, Yan Li, Ji-Guang Wang |
| 15 |
[GO] |
2021―Jul―30 |
Day-to-day blood pressure variability and severity of COVID-19: Is sympathetic overdrive a potential link? |
Michiaki Nagai, Takeshi Fujiwara, Kazuomi Kario |
| 16 |
[GO] |
2021―Jul―28 |
Influence of angiotensin converting enzyme inhibitors/angiotensin receptor blockers on the risk of all-cause mortality and other clinical outcomes in patients with confirmed COVID-19: A systemic review and meta-analysis |
Na Jia, Guifang Zhang, Xuelin Sun, Yan Wang, Sai Zhao, Wenjie Chi, Sitong Dong, Jun Xia, Ping Zeng, Deping Liu |
| 17 |
[GO] |
2021―Jun―25 |
Risk factors for the delayed viral clearance in COVID-19 patients |
Xiaoping Chen, Wenjia Hu MT, Miao Yang, Jiaxin Ling, Yongxi Zhang, Liping Deng, Jinlin Li, Åke Lundkvist, Johanna F Lindahl, Yong Xiong |
| 18 |
[GO] |
2021―May―06 |
Arterial stiffness and COVID-19: A bidirectional cause-effect relationship |
Sahrai Saeed, Giuseppe Mancia |
| 19 |
[GO] |
2021―Feb―15 |
Advancing hypertension management in Asia 2021, beyond COVID-19 |
Aletta E. Schutte |
| 20 |
[GO] |
2021―Feb―03 |
Disaster hypertension and cardiovascular events in disaster and COVID-19 pandemic |
Keisuke Narita, Satoshi Hoshide, Kelvin Tsoi, Saulat Siddique, Jinho Shin, Yook-Chin Chia, Jam Chin Tay, Boon Wee Teo, Yuda Turana, Chen-Huan Chen, Hao-Min Cheng, Guru Prasad Sogunuru, Tzung-Dau Wang, Ji-Guang Wang, Kazuomi Kario |
| 21 |
[GO] |
2021―Jan―25 |
Interactions between hypertension and inflammatory tone and the effect on blood pressure and outcomes in patients with COVID-19 |
Jacques Amar, Nicolas Touront, Antoine M. Ciron, Caroline Pendaries |
| 22 |
[GO] |
2020―Dec―25 |
The influence of diabetes and hypertension on outcome in COVID-19 patients: Do we mix apples and oranges? |
Marijana Tadic, Cesare Cuspidi |
| 23 |
[GO] |
2020―Dec―25 |
Is hypertension without any other comorbidities an independent predictor for COVID-19 severity and mortality? |
Martin R. Salazar |
| 24 |
[GO] |
2020―Dec―25 |
Independent and combined effects of hypertension and diabetes on clinical outcomes in patients with COVID-19: A retrospective cohort study of Huoshen Mountain Hospital and Guanggu Fangcang Shelter Hospital |
Yuhui Sun, Xizhou Guan, Lijing Jia, Ning Xing, Liuquan Cheng, Bo Liu, Sibing Zhang, Kunlun He |
| 25 |
[GO] |
2020―Nov―21 |
Hypertension, medications, and risk of severe COVID-19: A Massachusetts community-based observational study |
Ann Z. Bauer, Rebecca Gore, Susan R. Sama, Richard Rosiello, Lawrence Garber, Devi Sundaresan, Anne McDonald, Patricia Arruda, David Kriebel |
| 26 |
[GO] |
2020―Oct―25 |
COVID-19 and cardiovascular risk: Flying toward a silent world? |
Frédéric Dutheil, Julien S. Baker, Valentin Navel |
| 27 |
[GO] |
2020―Oct―02 |
Influence of blood pressure control and application of renin-angiotensin-aldosterone system inhibitors on the outcomes in COVID-19 patients with hypertension |
Renzheng Chen, Jie Yang, Xubin Gao, Xiaohan Ding, Yuanqi Yang, Yang Shen, Chunyan He, Hedong Xiang, Jingbin Ke, Fangzhengyuan Yuan, Ran Cheng, Hailin Lv, Ping Li, Limin Zhang, Chuan Liu, Hu Tan, Lan Huang |
| 28 |
[GO] |
2020―Sep―20 |
COVID-19, hypertension, and renin-angiotensin-aldosterone system inhibitors: Much ado about nothing or real problem to be solved? |
Marijana Tadic, Cesare Cuspidi |
| 29 |
[GO] |
2020―Sep―16 |
Randomized elimination and prolongation of ACE inhibitors and ARBs in coronavirus 2019 (REPLACE COVID) Trial Protocol |
Jordana B. Cohen, Thomas C. Hanff, Vicente Corrales-Medina, Preethi William, Nicolas Renna, Nelson R. Rosado-Santander, Juan E. Rodriguez-Mori, Jonas Spaak, Jaime Andrade-Villanueva, Tara I. Chang, Alejandro Barbagelata, Carlos E. Alfonso, Eduardo Bernales-Salas, Johanna Coacalla, Carlos Augusto Castro-Callirgos, Karen E. Tupayachi-Venero, Carola Medina, Renzo Valdivia, Mirko Villavicencio, Charles R. Vasquez, Michael O. Harhay, Jesse Chittams, Tiffany Sharkoski, James Brian Byrd, Daniel L. Edmonston, Nancy Sweitzer, Julio A. Chirinos |
| 30 |
[GO] |
2020―Sep―03 |
Reduction in environmental noise during COVID-19 pandemic and cardiovascular disease: A mystery for further investigation |
Christina Antza, Stella Stabouli |
| 31 |
[GO] |
2020―Aug―28 |
Increased cardiovascular death rates in a COVID-19 low prevalence area |
Rita Del Pinto, Claudio Ferri, Leondino Mammarella, Stefano Abballe, Sofia Dell'Anna, Sabrina Cicogna, Davide Grassi, Simona Sacco, Giovambattista Desideri |
| 32 |
[GO] |
2020―Jul―25 |
Use of distinct anti-hypertensive drugs and risk for COVID-19 among hypertensive people: a population-based cohort study in Southern Catalonia, Spain |
Angel Vila-Corcoles, Eva Satue-Gracia, Olga Ochoa-Gondar, Cristina Torrente-Fraga, Frederic Gomez-Bertomeu, Angel Vila-Rovira, Imma Hospital-Guardiola, Cinta Diego-Cabanes, Ferran Bejarano-Romero, Dolors Rovira-Veciana, Josep Basora-Gallisa |
| 33 |
[GO] |
2020―Jul―09 |
COVID-19 and hypertension-evidence and practical management: Guidance from the HOPE Asia Network |
Kazuomi Kario, Yuji Morisawa, Apichard Sukonthasarn, Yuda Turana, Yook-Chin Chia, Sungha Park, Tzung-Dau Wang, Chen-Huan Chen, Jam Chin Tay, Yan Li, Ji-Guang Wang |
| 34 |
[GO] |
2020―Jul―06 |
COVID-19 and arterial hypertension: Hypothesis or evidence? |
Marijana Tadic, Cesare Cuspidi, Guido Grassi, Giuseppe Mancia |
| 35 |
[GO] |
2020―May―30 |
COVID-19 and diabetes: Is there enough evidence? |
Marijana Tadic, Cesare Cuspidi, Carla Sala |
|
